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The Overview series
This publication series from the Drug Misuse Research Division of the
Health Research Board provides a comprehensive review of specific drug-
related issues in Ireland. Each issue in the series will examine, in an
objective and reliable manner, an aspect of the drugs phenomenon. It is
envisaged that each issue will be used as a resource document by policy
makers, service providers, researchers, community groups and others
interested in the drugs area.
Drug Misuse Research Division
The Drug Misuse Research Division is a multi-disciplinary team of
researchers and information specialists who provide objective, reliable and
comparable information on the drug situation, its consequence and
responses in Ireland. The Division maintains two national drug-related
surveillance systems and is the national focal point for the European
Monitoring Centre for Drugs and Drug Addiction. The Division also
manages the National Documentation Centre on Drug Use. The Division
disseminates research findings, information and news through its quarterly
newsletter, Drugnet Ireland, and other publications. Through its activities,
the Division aims to inform policy and practice in relation to drug use.
Health Research Board
The Health Research Board is a statutory body with a mission to improve
health through research and information. The Board is responsible for
promoting, commissioning and conducting medical, epidemiological and
health services research in Ireland. The Health Research Board carries out
these roles, and adds value, through competitive funding of health
research, participation in health research and maintaining national research
databases on disability, mental health and drug misuse.
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Glossary
Incidence is a term used to describe the number of new cases of disease
or events that develop among a population during a specified time
interval. For example, in 2001, ten opiate users living in a specific county
sought treatment for the first time. The incidence is the number of opiate
cases divided by the population living in the county (say 31,182 persons in
this example) expressed per given number of the population, i.e., per 100,
per 1,000, per 10,000, etc.
The calculation in this case is as follows: (10/31,182) x 10,000, which
gives an incidence rate of 3.2 per 10,000 of the specific county
population in 2001.
A confidence interval is the range of values (for example, proportions) in
which the true value is likely to be found. By convention, a 95 per cent
confidence interval is usually calculated, that is, the range of values will
include the true value 95 per cent of the time. 
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Summary
The data presented in this paper describe what is known about trends in
drug-related deaths and deaths among drug users in Ireland between
1990 and 2002. 
The current and potential sources of data in Ireland on drug-related deaths
and deaths among drug users are described. 
The analysis presented in this paper is based on data reported to the
General Mortality Register (GMR) and on studies that extracted data from
the coroners’ records, the Central Treatment List, and the AIDS surveillance
system, and on an epidemic investigation. 
This paper will assist policy makers, service planners and public health
practitioners to develop appropriate responses to the consequences of
problem drug use.
The main findings and their implications are: 
•   Between 1990 and 1994, there was a small but steady increase in the
number of drug-related deaths, from 7 to 19, reported by the GMR in
Ireland. Between 1995 and 2000, there was a substantial increase in
the number of drug-related deaths, from 43 to 119, and in 2001
there was a considerable decline (to 88) in the number of deaths. In
2002, the number of drug-related deaths increased marginally (to 91)
when compared to 2001. 
•   According to data from the GMR, almost all drug-related deaths
between 1991 and 1994 occurred in Dublin. Between 1995 and
2000, there was a substantial increase in drug-related deaths in
Dublin, from 39 to 90; and there was a steady increase in drug-related
deaths outside the Dublin area, from 4 to 29. In 2001, there was a
sharp decrease in the number of drug-related deaths in Dublin (to 55)
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and a continued increase in drug-related deaths outside Dublin (to 33
in 2001 and 35 in 2002). These data follow trends in treated problem
opiate use. 
•   From 1998 to 2001, the annual numbers of opiate-related deaths
extracted by Byrne (2001) from the Dublin coroners’ records were
consistently higher than those reported by the GMR. These variations
may be related to differences in the definition of opiate-related deaths
applied in each case. The GMR considers opiate-related deaths to be
those occurring as a direct result of opiate use, while Byrne
investigated all the coroners’ cases that tested positive for opiate use
and so included a broader range of opiate-related deaths. 
•   Following a review of the Dublin coroners’ cases, Byrne reported that
13 per cent of drug-related deaths were associated with imprisonment
or recent release from prison.
•   According to both the GMR and Byrne’s review of coroners’ data,
those who died as a result of drug use were older than their
counterparts in treatment, indicating an increased risk with age. As
expected, more men than women died.
•   Opiate-related deaths account for the largest proportion of deaths
among drug users in Ireland. The review of coroners’ cases found that
polysubstance use was common among drug users who had died. 
•   Injecting drug use was associated with infection and subsequent death.
•   The number of drug-related deaths extracted from the GMR using the
national definition differed slightly from those extracted using the
EMCDDA definition (Selection B), but the trends over time were similar. 
•   Deaths as an indirect result of drug use are not systematically
documented and have been assessed only in small-scale studies in
Drug-related deaths in Ireland, 1990–2002 
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Dublin city and county. The findings of these studies indicate an
underestimate in opiate-related deaths but provide little information
on deaths as a result of other drugs. A system is required to document
drug-related deaths and deaths among drug users.
•   The document Building on Experience: National Drugs Strategy
2001–2008 (Tourism, Sport and Recreation 2001: 118) identifies two
actions necessary to estimate the excess mortality among those who
misuse licit and illicit drugs. These actions are: first, to improve the
quality and quantity of data collected at the time of death so as to
increase the accuracy of the attributed cause of death; and second, to
develop an accurate mechanism for recording the number of drug-
related deaths in Ireland. This mechanism will include both drug-
related deaths and deaths among drug users.
•   Over the past number of years, the Department of Justice, Equality
and Law Reform, the Department of Health and Children, the
National Drugs Strategy Team and the Health Research Board (HRB),
in conjunction with the Central Statistics Office (CSO) and the
Coroner Service, have endeavoured to make this action a reality. 
•   In February 2005, the Department of Health and Children and the
Department of Justice, Equality and Law Reform requested the Drug
Misuse Research Division (DMRD) of the HRB to host a National Drug-
Related Deaths Index. 
TitleSummary
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Introduction
Problem drug use can lead to premature death. Deaths can occur as a
result of overdose (both intentional and unintentional), actions taken
under the influence of drugs, medical consequences and incidental causes.
Drug-related deaths and deaths among drug users are indicators of the
consequences of problem drug use in Ireland. Mortality trends allow us to
monitor the impact of prevention, harm reduction, treatment and
rehabilitation responses. 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
identifies drug-related deaths and deaths among drug users as one of the
five key indicators of drugs misuse in Europe. In each member state there
is a focal point for the collation of indicator data; the focal point in Ireland
is the Drug Misuse Research Division (DMRD) of the Health Research Board
(HRB).
In the strategy document Building on Experience: National Drugs Strategy
2001–2008 (Tourism, Sport and Recreation 2001: 118) the aspiration to
make this indicator a reality in Ireland is contained in Action 67: ‘To
develop an accurate mechanism for recording the number of drug-related
deaths in Ireland’. Over the past number of years, the Department of
Justice, Equality and Law Reform, the Department of Health and Children
and the HRB, in conjunction with the Central Statistics Office (CSO) and
the Coroner Service, have endeavoured to put this action into effect.
At present it is difficult to ascertain the exact number of deaths among
drug users in Ireland. The best estimate for Dublin ranges between 60 and
90 deaths per annum. However, the Family Support Network at Citywide
has indicated to the National Drugs Strategy Team that these figures
underestimate the extent of the problem. 
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Data sources
The current and potential data sources in Ireland on drug-related deaths
and deaths among drug users are described below. 
Central Statistics Office 
Situation to date
In Ireland, the CSO collates data on drug-related deaths extracted from the
General Mortality Register (GMR). The Registrar of Births, Deaths and
Marriages formally records all notified deaths in each jurisdiction.
Depending on the circumstances, deaths are notified by the Coroner
Service, hospitals or general practitioners. In addition, if the Gardai are
investigating a death on behalf of the Coroner Service, they provide
supplementary information related to the death to the CSO. Using data
from the GMR, the CSO then categorises the cause of each death using
the World Health Organization (WHO) diagnostic coding manual on the
international classification of diseases (known as ICD categories). The ninth
revision of the ICD manual continues to be used in this country. In Ireland,
the annual number of drug-related deaths is taken to be the aggregate
total number of deaths recorded under the ICD–9 category 304, which
relates to ‘a death by drug dependence’, plus those recorded under ICD 9
code 965.0, which refers to ‘poisoning by opiates and related narcotics’.
Using these definitions, the CSO extracts the numbers of drug-related
deaths (along with demographic information) and provides them to the
DMRD at the HRB. Staff at the DMRD analyse and report mortality data to
the EMCDDA in a predetermined format. The current national definition of
drug-related death differs from that recommended by the EMCDDA. 
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Situation recommended by the EMCDDA
At the European level, the EMCDDA (2002a) has developed a standardised
method for extracting drug-related deaths from the GMRs in all member
states. This standardised method selects certain drug-related death
categories and is known as ‘Selection B’. The broad diagnostic categories
and codes included in ‘Selection B’ are: drug psychoses (292), drug
dependence (304.0, 304.2-9), non-dependent drug abuse (305.2-3,
305.5-7, 305.9), accidental poisoning (E850.0, E850.8-9, E854.1-2,
E855.2, E855.9, E853.2, E851, E852, and E858.8-9), suicide and self-
inflicted poisoning (E950.0-5), and poisoning with intent undetermined
(E980.0-5). The substances causing death must be specified. For GMRs
using ICD-9, the number of poisoning deaths (E-codes) must be extracted
in combination with nature of injury codes (N-codes). The EMCDDA
recommends that its standardised method be introduced in Ireland from
the publication of this paper onwards. 
The GMR is one source of data on drug-related deaths. This paper presents
a comparison between the numbers of, and trends in, drug-related deaths
using Ireland’s national definition and the EMCDDA’s ‘Selection B’ method. 
Coroner Service
The primary objective of the Coroner Service in Ireland is to establish,
following public investigation, the cause of death (including how the
person died) in cases of sudden or unexpected death (Working Group
2000). The coroners do not establish criminal or civil liability. A coroner
must be either a registered medical practitioner (or be entitled to register
as such) or a practising solicitor or barrister. All appointees must have five
years’ experience in their respective professions. In Ireland, a coroner has
the same absolute privileges as a judge. 
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According to the review of the Coroner Service (2000), there are
approximately 32,000 deaths in Ireland annually; of these, approximately
7,250 (23%) become coroners’ cases, of which some 3,000 require post-
mortems. 
The coroner is informed of all reportable deaths. Reportable deaths are
sudden and unexpected deaths. Homicides, suicides, deaths from
unknown causes, and deaths during an operation are all examples of
reportable deaths. 
Once a death has been reported to the coroner, a cycle commences from
which an exit can be made at different stages. The coroner makes an
inquiry from which he can establish whether the cause of death and its
circumstances were natural or inexplicable. If the cause is deemed natural,
then the coroner issues a certificate to the Registrar of Births, Deaths and
Marriages, who in turn issues the death certificate. 
If the death is inexplicable, the coroner may order a post-mortem
(autopsy) to establish the cause of death. A pathologist examines the body
internally and externally to help determine the cause of death. Samples of
body fluids are sent for toxicological examination and tissues or complete
organs are sent for histological examination. This process can take a
number of months. If, after post-mortem, the cause is deemed natural,
then the coroner issues a certificate to the Registrar of Births, Deaths and
Marriages, who in turn issues the death certificate. A temporary certificate
can be issued in the interim. 
If the death remains inexplicable following post-mortem, the coroner may
order an inquest to establish the cause of death. An inquest must be held
in the case of all deaths that occur in a violent or unnatural manner, or
‘suddenly and from unknown causes’. The inquest is concerned with
establishing the facts of the death, namely, when, where and how the
death occurred. An inquest resembles a traditional court but its function is
to establish the facts rather than to determine innocence or guilt. The
Data sources
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inquest delivers a verdict on the cause of death; among the options are:
accidental, misadventure, suicide, open verdict, natural causes and
unlawful killing. Following the verdict, the coroner issues a certificate to
the Registrar of Births, Deaths and Marriages, who in turn issues the death
certificate. 
A number of authors (Ramsbottom and Harbison 1994; Keating et al.
1999; Byrne 2001; Ward and Barry 2001; Byrne 2002) examined the
records of individuals who had a post-mortem showing a positive
toxicological analysis of body fluids, and who died in the Dublin city and
county area during a number of separate time periods. These studies
identified all cases with a positive toxicological analysis of body fluids,
whether or not this was the primary cause of death. The Coroner Service is
an important source of data on drug-related deaths and deaths among
drug users. This paper presents an overview of studies using data from the
Coroner Service. 
Central Treatment List
The Central Treatment List was established under Statutory Instrument No.
225 (Minister for Health and Children 1998) following the Report of the
Methadone Treatment Services Review Group 1998. This list is administered
by the Drug Treatment Centre Board on behalf of the Health Service
Executive and is a complete register of all patients receiving methadone
(for treatment of opiate misuse) in Ireland. When a person is considered
suitable for methadone detoxification or maintenance, the prescribing
doctor applies to the Central Treatment List for a place on the list and a
unique number is allocated to each client. Therefore, each client can
receive their methadone from one source only. Each client’s’ name,
address, date of birth, gender, date commenced on methadone, type of
methadone treatment, prescribing doctor and dispensing pharmacist are
recorded on the Central Treatment List. The Central Treatment List is
considered complete with respect to the number of clients who start or
recommence methadone because practitioners have a statutory obligation
Drug-related deaths in Ireland, 1990–2002 
to report the initiation of treatment and, also, they are paid per client in
treatment. Once on the list, there are transfer and exit forms for the
Central Treatment List to track each client’s current treatment status. One
of the outcomes on the exit form is death; therefore, it is possible to use
the Central Treatment List as a source to identify drug-related deaths and
deaths among drug users. The number of exits from and transfers within
the Central Treatment List has never been validated. As already mentioned,
each client has a unique identifier so duplicates or transfers between
treatment providers can be easily identified, but it is possible that a
proportion of exits are not reported promptly, in particular those who drop
out of treatment or die. For example, Cullen and colleagues (2001) were
unable to locate 17 per cent of cases registered as attending methadone
maintenance treatment in selected general practices in Dublin and on the
Central Treatment List. More recently, nurses in the East Coast Health
Authority area reported that, following an audit of their charts, their actual
numbers in treatment between 2001 and 2003 were ten per cent less than
the numbers on the Central Treatment List (A Tierney, personal
communication, 2004). A retrospective cohort study of people who started
methadone treatment between January 1994 and December 1997 was
conducted to estimate the incidence of deaths among drug users
(EMCDDA 2002b). This is a source of data on drug-related deaths and
deaths among drug users. This paper presents an overview of the main
findings from this study. 
AIDS surveillance system
AIDS reporting in Ireland is a voluntary system. When an individual
develops AIDS, the clinician completes an anonymised AIDS surveillance
form. The form is then sent to the regional AIDS co-ordinator in the
relevant Health Service Executice Area, who, in the past, forwarded this to
the national AIDS co-ordinator in the Department of Health and Children
(DOHC). Every six months, a summary of AIDS surveillance information
was published nationally and was notified to the European Centre for the
Epidemiological Surveillance of AIDS. In November 2000, the Health
Drug Misuse Research Division 27
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Protection Surveillance Centre (HPSC) assumed responsibility for national
AIDS surveillance from the DOHC. This is a source of data on drug-related
deaths and deaths among drug users. Data on the incidence of AIDS and
deaths among those with AIDS are published every six months, but the
number of drug users who died has not been consistently reported since
1999. This paper presents an overview of published data (O’Donnell et al.
2000; National Disease Surveillance Centre 2001, 2002, 2003). 
Epidemic investigation
In Ireland an unexpected rise in the number of, or an unusual occurrence
of, new cases of an infectious disease are investigated routinely by the
relevant public health department in collaboration with the HPSC. Mullen
et al. (2002) published a case-control study that investigated an outbreak
of Clostridium Novyi (an anaerobic organism) among heroin users living in
Dublin.
Hospital In-Patient Enquiry (HIPE) scheme 
The Economic and Social Research Institute manages the Hospital In-
Patient Enquiry (HIPE) scheme in Ireland. The scheme is a computer-based
health information system designed to collect clinical and administrative
data on discharges and deaths from acute public hospitals. Each HIPE
discharge record represents one episode of care; patients may be admitted
to hospital(s) more than once with the same or different diagnoses. The
records therefore facilitate analyses of hospital activity rather than
incidence of disease. All discharges from acute hospitals are coded using
ICD–9 classification (WHO 1977). Over 60 acute public hospitals
participate in the scheme. Casualty and outpatient data are not collected.
The estimated coverage of all cases discharged from acute hospitals in the
HIPE scheme was approximately 95 per cent between 1996 and 2000.
Those who died with a history of drug dependence could be abstracted
from this database. This is a source of data on drug-related deaths and
deaths among drug users. This data source has never been used to
Drug-related deaths in Ireland, 1990–2002 
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examine the incidence of drug-related deaths or deaths among drug users
in acute hospitals. 
Data sources
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Analysis of data and information
The analysis presented in this paper is based on data reported to the GMR
and studies that extracted data from the Coroner Service, the Central
Treatment List and the AIDS surveillance system, and on an epidemic
investigation.
Direct drug-related deaths
In Ireland, the CSO compiles the GMR’s official statistics on direct drug-
related deaths each year. 
The CSO categorises the cause of each death using the World Health
Organization (WHO) diagnostic coding manual on the international
classification of diseases (known as ICD categories). The ninth revision of
this manual continues to be used in this country. 
In Ireland, the national definition for drug-related deaths consists of
categories 304 (0-9) and 965.0 (see Data sources). At the European level,
the EMCDDA (2002a) has developed a standardised method that selects a
number of diagnostic categories and is known as ‘Selection B’ (see Data
sources). 
Table 1 presents the number of direct drug-related deaths, by cause of
death, in Ireland from 1990 to 2002, using the national (Ireland) and
European (EMCDDA Selection B) definitions. The differences between the
total numbers of drug-related deaths extracted using the European
definition compared to total numbers extracted using the national
definition are due to a number of factors. Using the European definition,
the numbers of cases each year in the drug dependence category are
lower than the numbers extracted using the national definition; this is
explained by the exclusion of barbiturate-type drugs from the European
definition. For the European definition, the poisoning categories include a
larger number of codes to extract cases than the number of codes used to 
34 Drug Misuse Research Division
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extract cases for the national definition and, therefore, the numbers of
cases extracted under the poisoning categories are higher when using the
European definition than when using the national definition. Non-
dependent abuse of drugs and drug psychosis are additional categories
included in the European definition, which are not included in the national
definition. 
Figure 1 presents the number of direct drug-related deaths in Ireland from
1990 to 2002 by national and European definitions. When the numbers
extracted using the European definition were compared to those extracted
using the national definition, the numbers of drug-related deaths were
lower using the European criteria between 1995 and 1998, while the
numbers were higher in 1999 and 2001, but the differences were small
and the trend over time was the same. Between 1990 and 1994, there was
Analysis of data and information
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Figure 1  Number of direct drug-related deaths in Ireland, by national
and by European definition, reported by the CSO, 1990 to 2002
(unpublished data from the vital statistics)
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a small but steady increase in the number of drug-related deaths. Between
1995 and 2000, there was a substantial increase in the number of drug-
related deaths and in 2001 there was a considerable decline in the number
of deaths. In 2002, the number of drug-related deaths increased
marginally when compared to 2001. 
It has been reported that improved coding was one factor that accounted
for the increase in drug-related deaths recorded between 1992 and 2000,
but further investigation of the situation would not support this view. The
main recording change was the introduction of a revised version of Form
104 in 1998. In the ideal situation, the coroner’s verdict includes a medical
diagnosis and the circumstances under which the death occurred. A small
number of coroners outside the Dublin area do not currently include
details of the circumstances under which the death occurred (B Farrell,
personal communication, 2005). According to the Coroner Service, the
data primarily affected by this omission related to suicide. In order to
address this problem, in 1998 Form 104 was revised by the CSO for
completion by the Garda Síochána after the inquest. This was done to
supplement a coroner’s conclusion when it included a medical diagnosis
but did not record details of the circumstances under which the death
occurred. Officials at the Coroner Service reported that this would have
had little effect on the total number of drug-related deaths (B Farrell,
personal communication, 2005). Data presenting trends in treated
problem drug use (in particular treated problem opiate use), which are an
indirect indicator of problem drug use in the wider community,
demonstrate that the trend in drug-related deaths observed in Ireland
follows that of new opiate cases seeking treatment for problem drug use,
which is an indirect indicator of problem drug use in a community.  
Figure 2 presents the number of direct drug-related deaths in Dublin and
the rest of Ireland from 1990 to 2002 by national and European
definitions. According to data from the GMR, almost all drug-related
deaths between 1991 and 1994 occurred in Dublin. Between 1995 and
2000, there was a substantial increase in drug-related deaths in Dublin,
Drug-related deaths in Ireland, 1990–2002 
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from 39 to 90; and there was a steady increase in drug-related deaths
outside the Dublin area, from 4 to 29. In 2001, there was a sharp decrease
in the number of drug-related deaths in Dublin (to 55) and a continued
increase in drug-related deaths outside Dublin (to 33 in 2001 and 35 in
2002). These data follow trends in treated problem opiate use. 
Figure 3 presents the average age of cases of direct drug-related death
between 1990 and 2002, by national and by European definition. When
the average age of death for those who died as a result of a direct drug-
related incident using the European definition was compared to the
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Figure 2  Number of direct drug-related deaths in Ireland, by national
and by European definition and by place of death, reported by the CSO,
1990 to 2002 (unpublished data from the vital statistics)
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average age using the national definition, the average at death was lower
using the European definition between 1994 and 2002, but the trend over
time was the same. Between 1990 and 2001, the average age of cases
who died as a result of a direct drug-related incident increased steadily,
from just under 22 years to around 37 years. This was higher than the
average age of those treated for problem drug use and indicates a higher
risk of death among older drug users. 
Figure 4 presents the number of direct drug-related deaths, by gender,
reported from 1990 to 2002 using national and European definitions.
When the numbers of males extracted using the European definition were
compared to those extracted using the national definition, the numbers of
drug-related deaths among men were lower using the European definition
in 1996 and 1997, while the numbers were higher in 1999 and 2001, but
the differences were small. When the numbers of females extracted using
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Figure 3  Average age of cases of direct drug-related death in Ireland,
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2002 (unpublished data from the vital statistics)
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the European definition were compared to those extracted using the
national definition, the numbers of drug-related deaths among women
were similar, except in 1998, when the number extracted using the
European definition was lower. The vast majority of drug-related deaths
occur in men, which is not surprising since the vast majority of drug users
are men. Of note, there was a steady increase in the number of drug-
related deaths in women between 1994 and 2000 and a levelling off in
2001 and 2002. The number of drug-related deaths in males increased
steadily between 1990 and 1993, and more dramatically between 1994
and 1999; and between 2000 and 2001 there was a sharp decrease in the
number of men who died. 
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Figure 5 presents the incidence of direct drug-related deaths between
1996 and 2002 per 100,000 population aged between 15 and 64 years,
using the national and European definitions. Though the incidence by each
definition varies slightly each year, the incidence curve follows a similar
trend. The incidence of drug-related deaths per 100,000 of the population
aged between 15 and 64 years doubled between 1996 and 2000, but
decreased sharply in 2001 and in 2002 remained similar to 2001. 
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Findings of ad hoc studies on direct and indirect drug-related
deaths 
This section presents the findings of a number of independent studies
examining drug-related deaths and deaths among drug users. 
Coroner Service
Deaths as a direct result of drug use are systematically documented by the
GMR, but this has limitations. Deaths as an indirect result of drug use are
not systematically documented and have been assessed only in small scale-
studies in Dublin city and county. 
In the mid to late nineties, Dublin was the epicentre of the opiate
epidemic in Ireland and the number of cases who tested positive for
opiates investigated by the Dublin City and County Coroners increased
from 77 in 1998 to 91 in 2000, and decreased in 2001 to 78.
Ramsbottom and Harbison (1994) examined the records of individuals
who had a post-mortem showing a positive toxicological analysis of body
fluids and who died between January 1992 and December 1992 in the
Dublin city and county area. In total, there were 68 cases that fulfilled the
criteria, 32 per cent of whom were known drug users. Of the 68 deaths,
three (4%) died from incidental causes; 49 (72%) as a result of
intoxication; 15 (22%) had committed suicide; and one (1.5%) was
accidental. In the case of the 65 who died directly as a result of their drug
consumption, tranquillisers (48, 74%) and alcohol (28, 43%) were the
most common detected drugs during toxicological analysis. The authors
reported that tricyclic antidepressants and morphine were also common,
but did not provide any data to support this statement. 
Using the same methods, Keating et al. (1999) examined the records of
individuals who died between January 1997 and December 1997 in the
Dublin city and county area. In total, 120 cases had a positive toxicological
analysis of body fluids. Of the 120 cases, 75 per cent were men. The
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average age of the men was 30 years; that of the women was 42 years. Of
all cases investigated, 54 per cent were known habitual drug users. Habitual
drug users were younger than non-habitual drug users. For example, the
mean age at death for male habitual drug users was 26 years and for male
non-habitual drug users was 36 years. Overall, the results indicate that
polydrug use was common, 50 cases tested positive for two or three drugs.
Of the 120 cases reviewed, 27 tested positive for heroin, of whom all tested
positive for benzodiazepines and 15 (56%) tested positive for alcohol. 
Between January 1998 and December 2001, the Dublin City and County
Coroners’ Office investigated 332 opiate-related deaths in Dublin (Figure 6).
Byrne (2002) collated and analysed this data. Over the four years, more than
two-thirds (65%, 224/342) of those who died were between 15 and 34 years
old and the majority (87%) were men. Fifty-six per cent were alone when
they died. Over half died in their homes and 16 per cent died in a public
space. Thirty-two (13%) of those who died were either in prison (6) or had
just been released from prison (26), denoting a high-risk period (Byrne 2001). 
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Figure 6  Numbers of opiate-related deaths recorded by the Dublin
coroners, 1998 to 2001 (adapted from Byrne 2002) 
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Between 1998 and 2001, just over 90 per cent (300/332) of the coroners’
cases resided in the local drugs task force areas. Opiate-related death rates
were calculated using the 2002 census population for each task force area
(Figure 7). The Ballymun, Ballyfermot, and Canal Communities task force
areas had the higher rates of opiate-related deaths for the reporting 
period, approximately 16 times the rate experienced in areas of Dublin not
designated as task force areas. Both the North and South Inner City had
opiate-related death rates over seven times the rate experienced in areas of
Analysis of data and information
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Figure 7  Average annual rate of opiate-related deaths in each Dublin-
based local drugs task force area compared to other areas of Dublin,
per 100,000 of the 15 to 64-year-old population using Dublin coroners’
records, 1998 to 2001 (numerators adapted from Byrne 2002;
denominators from Census 2002, Volume 1)
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Dublin not designated as task force areas. Dun Laoghaire–Rathdown had
an opiate-related death rate approximating the rate experienced in areas
of Dublin not designated as task force areas.
Two-thirds of the opiate users who died tested positive for three or more
drugs, while just over 11 per cent tested positive for one drug (Byrne
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2001). The drugs most frequently detected were benzodiazepines (68%)
heroin (62%), methadone (57%), alcohol (47%) cannabis (20%)
antidepressants (11%) and cocaine (6%) (Figure 8). Among the eight
drugs most commonly implicated in drug-related deaths, two distinct
patterns were observed: benzodiazepines, opiates (heroin and
methadone), and alcohol were by far the most common substances
implicated in these deaths, while cannabis, antidepressants, and stimulants
(ecstasy and cocaine) were less commonly implicated. 
Using the same source as Byrne, Ward and Barry (2001) determined that
there were 84 opiate-related deaths in 1999 and that 45 (54%) were
methadone-related deaths. Of the methadone-related deaths, 15 (33%)
were receiving methadone according to prescribed guidelines. 
Agreement between the CSO and Dublin City and County Coroners’
Office
From 1998 to 2001, the annual numbers of opiate-related deaths
extracted by Byrne (2001) from the Dublin Coroners’ records were
consistently higher than those reported by the GMR. These variations may
be related to differences in the definition of opiate-related deaths applied
in each case. The GMR considers opiate-related deaths to be those
occurring as a direct result of opiate use, while Byrne investigated all the
coroners’ cases that tested positive for opiate use and so included a
broader range of opiate-related deaths.
Kelly et al. (2002) estimated the number of opiate users in Ireland in 2000
using a capture–recapture study methodology involving subjects contained
in three national databases. The authors reported that there was an
estimated 12,456 (95% confidence interval 11,519 to 13,711) opiate users
in Dublin in 2001. Using these estimates and data from Dublin City and
County Coroners’ Office, the estimated opiate-related death rate 
among the opiate-using population was 64 per 10,000 (95% confidence
interval 58 to 69) in 2001.
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Central Treatment List
A retrospective longitudinal cohort study of people who started
methadone treatment between January 1994 and December 1997 was
conducted to estimate mortality among drug users (EMCDDA 2002b). The
Central Treatment List was the data source used for this study. During the
recruitment period, 5,283 individuals commenced methadone treatment
and were recruited to participate in the study. Of these, 3,909 (74%) were
alive at the end of 1997; 113 (2%) had died between recruitment and the
end of 1997. At the end of the study, 1,261 (24%) could not be located;
this high loss to follow-up could bias the results. The overall death rate was
13.9 per 1,000 person years, and was higher in males (15.8) than in
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females (9.4). The death rate, expressed per 1,000 person years, was 11.0
in 1994, 13.2 in 1995 (J Vincente, personal communication, 2003), 16.1 in
1996 and 9.6 in 1997. As the incidence measure is person years rather
than a cumulative rate over a period of time, it is not possible to compare
the findings of this study with other studies in Ireland. Data were not
presented on cause of death but further analysis is pending (J Barry,
personal communication, 2004). 
Deaths as a result of infectious diseases
Of the 729 AIDS cases between 1983 and 2001, 373 died (O’Donnell et al.
2000; National Disease Surveillance Centre 2001, 2002, 2003). Of the 292
cases who had injecting drug use as a risk factor between 1983 and 1999,
166 (57%) died. The proportion of injecting drug users diagnosed with
AIDS who died was higher than both the proportion of heterosexuals
(38%) and the proportion of men who have sex with men (49%). This
indicates a probable lower survival rate among injecting drug users with
HIV compared to counterparts with other risk practices. The data on
deaths by risk group have not been updated since 1999. 
Mullen et al. (2002) investigated an outbreak of Clostridium Novyi (an
anaerobic organism) among heroin users living in Dublin using a case-
control study design. Between 29 April and 26 June 2000 there were 22
cases, of whom eight (36%) died. The illness was characterised by soft
tissue inflammation at the injection site, low blood pressure and circulatory
collapse. After controlling for confounding factors, it was found that drug
users who injected into the muscle were 27 times more likely to develop
symptomatic illness than those who injected via another route (such as,
intravenous or subcutaneous). Injecting into the muscle is usually done
when venous access is difficult because of scarring of veins from repeated
use. The authors caution that if bacterial spores are contained in the
heroin, then needle-exchange programmes cannot prevent such infections. 
Analysis of data and information
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Conclusions
In Ireland, the number of direct drug-related deaths increased substantially
between 1994 and 2000 and decreased in 2001. Most of these deaths
occurred in Dublin but there was a steady increase in the number of
deaths outside Dublin. Those who died as a result of drug use were older
than their counterparts in treatment. As expected, more men than women
died. Opiate-related deaths accounted for the largest proportion of deaths
among drug users. Polysubstance use was associated with deaths among
drug users. Injecting drug use was associated with infection and
subsequent death. Following a review of coroners’ cases, Byrne reported
that 13 per cent of drug-related deaths occurred in prison or within a short
time after release from prison. Overdose prevention interventions using
international and national experience and evidence are required. 
The number of drug-related deaths extracted using the national definition
and the EMCDDA definition (Selection B) differed slightly but the trends
over time were similar. 
Deaths as an indirect result of drug use are not systematically documented
and have been assessed only in small-scale studies in Dublin city and
county. The findings of these studies indicate an underestimate in opiate-
related deaths but provide little information on other drug-related deaths.
A system is required to document drug-related deaths and deaths among
drug users.
The document Building on Experience: National Drugs Strategy 2001–2008
(Tourism, Sport and Recreation 2001: 118) identifies two actions necessary
to estimate the excess mortality among those who misuse licit and illicit
drugs. These actions are: first, to improve the quality and quantity of data
collected at the time of death so as to increase the accuracy of the
attributed cause of death; and second, to develop an accurate mechanism
for recording the number of drug-related deaths in Ireland. 
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This mechanism will include both drug-related deaths and deaths among
drug users. Over the past number of years, the Department of Justice,
Equality and Law Reform, the Department of Health and Children, the
National Drugs Strategy Team and the HRB, in conjunction with the CSO
and the Coroner Service, have endeavoured to make this action a reality. In
February 2005, the Department of Health and Children and the
Department of Justice, Equality and Law Reform requested the DMRD of
the HRB to host a National Drug-Related Deaths Index. 
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